课题基金 / 基金详情

Anticardiolipin Antibodies and Obstructive Vascular Events

Anticardiolipin Antibodies and Obstructive Vascular Events
抗心磷脂抗体和阻塞性血管事件
批准号:
11470122
负责人:
KOIKE Takao
金额:
$9.09万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

KOIKE Takao的其他基金

相关文献

中文摘要
翻译
抗磷脂抗体(抗心磷脂抗体(ACL)和狼疮抗凝剂(LA))患者经常出现动脉和/或静脉血栓形成、反复胎儿丢失和血小板减少。术语抗磷脂综合征(APS)被用来定义这一组病理特征。最近的证据表明,抗磷脂抗体可能参与了动脉粥样硬化病变的形成。在45岁以下的系统性红斑狼疮患者中,心肌梗死已被认为是主要的致死原因。我曾报道在AP患者中发现的aCL不是简单地针对CL结构,而是需要β2-糖蛋白I(β2GPI)的存在才能与之结合,其表位是通过β2GPI与氧取代的固体表面相互作用时发生的构象变化来表达的。1)抗心磷脂抗体的存在是血栓形成和动脉粥样硬化的危险因素。2)我们发现了β2GPI缺陷家族,命名为β2GPI-Sapporo。3)β2GPI基因多态性影响acl表位的形成和aCL的发生。
英文摘要
Arterial and/or venous thrombosis, recurrent fetal loss and thrombocytopenia are frequently found in patients with antiphospholipid antibodies (anticardiolipin antibodies (aCL) and lupus anticoagulant (LA)). The term antiphospholipid syndrome (APS) has been used to define this set of pathologic features.. Recent evidence suggested that antiphospholipid antibodies may have contributed to the formation of atherosclerotic lesions. In SLE less than 45 years of age, myocardial infarction has been recognized as a major cause of mortality.I have reported that aCL found in patients with APS are not simply directed to the CL structure, but require the presence of β2-glycoprotein I (β2GPI) for bindng and that the epitopes is expressed by conformational changes occurring when β2GPI interacts with an oxygen-substituted solid surface.I performed the reserch project, entitled "Anticardiolipin Antibodies and Obstructive Vascular Events" from 1999 to 2001 and obtained the following results ;1) Presence of anticardiolipin antibodies is risk factors for thrombus formation and atherosclerosis.2) We discovered the β2GPI-deficient families and named β2GPI-Sapporo.3) Genetic polymorphysm of β2GPI is influenced on the epitope formation of aCL and on the development of APS
期刊论文(62)
专著(0)
科研奖励(0)
会议论文
小池隆夫: "β2-blycoprotein I deficiency : prevalence, genetic background and effects on plasma lipoprotein metabolism and hemostasis."Atherosclerosis.. 152. 337-346 (2000)
Takao Koike:“β2-糖蛋白 I 缺乏症:患病率、遗传背景以及对血浆脂蛋白代谢和止血的影响。”动脉粥样硬化.. 152. 337-346 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
小池隆夫: "Anticardiolipin Antibody, Thrombosis and Atherosclerosis."The Decade of Autoimmunity.. 9 (1999)
Takao Koike:“抗心磷脂抗体、血栓形成和动脉粥样硬化。”自身免疫的十年.. 9 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Koike T: "Anticardiolipin Antibody, Thrombosis and Atherosclerosis. Y.Shoenfeld ed.in The Decade of Autoimmunity."Elsevier Science B.V.. 9 (1999)
Koike T:“抗心磷脂抗体、血栓形成和动脉粥样硬化。Y.Shoenfeld 编辑,《自身免疫的十年》。”Elsevier Science B.V.. 9 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
小池隆夫: "Heterogeneous behavior anti-β2-glycoprotein."J.Rheumatol.. 72:2. 391-397 (2000)
Takao Koike:“异质行为抗 β2-糖蛋白”。J.Rheumatol.. 72:2 (2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 31 条
    The analysis of molecular pathogenesis and mechanisms for antiphospholipid syndrome
    • 批准号:
      22390198
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2010
    • 负责人:
      KOIKE Takao
    • 依托单位:
    Rural Homelessness in Japan with a special focus on the Tohoku Region
    • 批准号:
      19730357
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $1.57万
    • 财政年份:
      2007
    • 负责人:
      KOIKE Takao
    • 依托单位:
    Pathogenesis of antiphospholipid syndrome and new therapeutic target
    • 批准号:
      19390269
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2007
    • 负责人:
      KOIKE Takao
    • 依托单位:
    Pathogenesis of antiphospholipid antibodies:
    • 批准号:
      17390286
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.79万
    • 财政年份:
      2005
    • 负责人:
      KOIKE Takao
    • 依托单位: